drugset / Trial / NCT00004030
VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of VX-853 in treating patients who have solid tumors who are receiving liposomal doxorubicin.
Timeline
- Start
- 1996-03
- Primary completion
- 2001-01
- Completion
- 2001-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TIMCODAR | Small molecule | — | Oral |
| Background | Doxorubicin | Other / unclassified | — | Intravenous |